腹腔镜袖状胃切除术治疗肥胖症及其合并疾病的疗效分析

doi:10.3877/cma.j.issn.1674-0793.2020.04.005

目的

探讨腹腔镜袖状胃切除术（LSG）治疗肥胖症患者的减重效果及其对合并疾病的改善情况，评估手术安全性。

方法

回顾性分析2016年1月至2018年12月在贵州省人民医院接受LSG手术的58例肥胖症患者临床资料，观察患者术后减重效果、合并疾病改善情况及术后并发症发生情况。

结果

患者均顺利完成LSG手术，术后第3、6、12个月平均多余体质量减轻百分比（%EWL）分别为（65.4±12.3）%、（71.2%±15.2）%、（74.7±16.7）%；合并疾病脂肪肝、肝功能异常、血脂异常、呼吸睡眠暂停综合征、高血压、2型糖尿病和高尿酸血症的术后1年疾病缓解率分别为74.3%、78.3%、70.0%、56.3%、85.7%、100.0%、80.0%，术后均得到显著改善（P<0.05）。术后近期并发症发生率为3.4%（2/58），远期并发症主要为胃食管反流症、胆囊结石和急性胰腺炎。

结论

LSG可有效减轻肥胖患者的体质量，改善肥胖相关合并疾病，而且手术并发症发生率较低，相对安全，值得推广。

关键词: 胃切除术, 肥胖症, 多余体质量减轻百分比, 合并疾病, 并发症

Objective

To analyze the effectiveness and safety of laparoscopic sleeve gastrectomy (LSG) in treating obesity and its co-morbidities.

Methods

The clinical data of fifty-eight patients with obesity who underwent LSG in Guizhou Provincial People’s Hospital from January 2016 to December 2018 were retrospectively analyzed. The effect of weight loss, the improvement of combined diseases and postoperative complications were observed.

Results

All operations were successfully completed in LSG. The mean %EWL at 3, 6 and 12 months after surgery were (65.4±12.3)%, (71.2%±15.2)% and (74.7±16.7)% respectively. The combined diseases were fatty liver, liver dysfunction, dyslipidemia, obstructive sleep apnea, hypertension, type 2 diabetes mellitus and hyperuricemia, which were significantly improved by 74.3%, 78.3%, 70.0%, 56.3%, 85.7%, 100.0% and 80.0% one year after surgery. Early complications occurred in 3.4% (2/58) of patients, and the common late complications were gastroesophageal reflux disease, cholecystolithiasis and acute pancreatitis.

Conclusion

LSG is effective and safe in treating obesity and its co-morbidities.

Key words: Gastrectomy, Obesity, Percentage of excess weight loss, Combined diseases, Complication

表1 58例肥胖症患者术前及术后12个月合并疾病的改善情况[例(%)]

时间	脂肪肝	肝功能异常	血脂异常	呼吸睡眠暂停综合征	高血压	2型糖尿病	高尿酸血症
术前	35(60.3)	23(39.7)	20(34.4)	16(27.6)	14(24.1)	11(19.0)	10(17.2)
术后12个月	9(32.8)	5(8.6)	6(10.3)	7(12.1)	2(3.4)	0(0)	2(3.4)
χ2值	24.752	15.253	9.716	4.393	10.440	12.152	5.949
P值	<0.001	<0.001	0.002	0.036	0.001	<0.001	0.015

表1 58例肥胖症患者术前及术后12个月合并疾病的改善情况[例(%)]

时间	脂肪肝	肝功能异常	血脂异常	呼吸睡眠暂停综合征	高血压	2型糖尿病	高尿酸血症
术前	35(60.3)	23(39.7)	20(34.4)	16(27.6)	14(24.1)	11(19.0)	10(17.2)
术后12个月	9(32.8)	5(8.6)	6(10.3)	7(12.1)	2(3.4)	0(0)	2(3.4)
χ2值	24.752	15.253	9.716	4.393	10.440	12.152	5.949
P值	<0.001	<0.001	0.002	0.036	0.001	<0.001	0.015

图1 58例肥胖症患者腹腔镜袖状胃切除术后体质量减轻情况　A为体质量；B为体质指数（BMI）；C为多余体质量减轻百分比（%EWL）；*P<0.05，**P<0.01

[1]	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖和2型糖尿病外科治疗指南(2014) [J]. 糖尿病临床, 2014, 8(11): 499-504.
[2]	Vranešić Bender D, Krznarić Z. Nutritional and behavioral modification therapies of obesity: facts and fiction[J]. Dig Dis, 2012, 30(2): 163-167.
[3]	Rebibo L, Maréchal V, De Lameth I, et al. Compliance with a multidisciplinary team meeting’s decision prior to bariatric surgery protects against major postoperative complications[J]. Surg Obes Relat Dis, 2017, 13(9): 1537-1543.
[4]	Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery or intensive medical therapy for diabetes after 5 years[J]. N Engl J Med, 2017, 376(20): 1997.
[5]	Helmiö M, Victorzon M, Ovaska J, et al. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up[J]. Scand J Surg, 2014, 103(3): 175-181.
[6]	Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in asian Indian adults[J]. Diabetes Care, 2003, 26(5): 1380-1384.
[7]	Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient[J]. Obes Surg, 2004, 14(4): 492-497.
[8]	Boza C, Daroch D, Barros D, et al. Long-term outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure[J]. Surg Obes Relat Dis, 2014, 10(6): 1129-1133.
[9]	Deitel M, Gagner M, Erickson AL, et al. Third International Summit: current status of sleeve gastrectomy[J]. Surg Obes Relat Dis, 2011, 7(6): 749-759.
[10]	Rawlins L, Rawlins MP, Brown CC, et al. Sleeve gastrectomy: 5-year outcomes of a single institution[J]. Surg Obes Relat Dis, 2013, 9(1): 21-25.
[11]	Wang X, Chang XS, Gao L, et al. Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: A 3-year outcome from Mainland Chinese patients[J]. Surg Obes Relat Dis, 2016, 12(7): 1305-1311.
[12]	Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial[J]. JAMA, 2018, 319(3): 255-265.
[13]	Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial[J]. JAMA, 2018, 319(3): 241-254.
[14]	Nath A, Leblanc KA, Hausmann MG, et al. Laparoscopic sleeve gastrectomy: our first 100 patients[J]. JSLS, 2010, 14(4): 502-508.
[15]	Pradarelli JC, Varban OA, Ghaferi AA, et al. Hospital variation in perioperative complications for laparoscopic sleeve gastrectomy in Michigan[J]. Surgery, 2016, 159(4): 1113-1120.
[16]	Nath A, Yewale S, Tran T, et al. Dysphagia after vertical sleevegastrectomy: evaluation of risk factors and assessment of endoscopic intervention[J]. World J Gastroenterol, 2016, 22(47): 10371-10379.
[17]	Abou Rached A, Basile M, El Masri H. Gastric leaks post sleeve gastrectomy: review of its prevention and management[J]. World J Gastroenterol, 2014, 20(38): 13904-13910.
[18]	Gehrer S, Kern B, Peters T, et al. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)-a prospective study[J]. Obes Surg, 2010, 20(4): 447-453.
[19]	Durmush EK, Ermerak G, Durmush D. Short-term outcomes of sleeve gastrectomy for morbid obesity: does staple line reinforcement matter?[J]. Obes Surg, 2014, 24(7): 1109-1116.

[1]	金鑫, 谢卯, 刘芸, 杨操, 杨述华, 许伟华. 个性化股骨导向器辅助初次全髋关节置换的随机对照研究[J]. 中华关节外科杂志(电子版), 2023, 17(06): 780-787.
[2]	易晨, 张亚东, 董茜, 唐海阔, 刘志国. 应用骨盖技术拔除下颌低位骨性埋伏阻生第三磨牙的疗效观察[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 424-429.
[3]	杜滨和, 徐楠, 杨云川, 崔培元. 5项改良衰弱指数预测胰十二指肠切除术近期预后的价值探讨[J]. 中华普通外科学文献(电子版), 2023, 17(06): 444-448.
[4]	李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[5]	逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[6]	杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[7]	曹智, 朱希望, 王尉, 张辉, 杨成林, 张小明. 经皮肾镜碎石取石术中不同肾盂内压力与围术期并发症相关性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 616-620.
[8]	代格格, 杨丽, 胡媛媛, 周文婷. 手术室综合干预在老年腹股沟疝患者中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 759-763.
[9]	王敏, 蒋家斌, 李茂新. 预警宣教联合个性化疼痛管理对腹股沟疝手术患者的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 764-767.
[10]	戴玮, 江桂林, 车兆平, 张姣, 王星星, 赵海涛. 无缝手术护理在腹股沟疝腹腔镜手术围手术期的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 778-781.
[11]	叶晋生, 路夷平, 梁燕凯, 于淼, 冀祯, 贺志坚, 张洪海, 王洁. 腹腔镜下应用生物补片修补直肠术后盆底缺损的疗效[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 688-691.
[12]	袁伟, 张修稳, 潘宏波, 章军, 王虎, 黄敏. 平片式与填充式腹股沟疝修补术的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 697-701.
[13]	潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[14]	牛朝, 李波, 张万福, 靳文帝, 王春晓, 李晓刚. 腹腔镜袖状胃切除联合胆囊切除治疗肥胖合并胆囊结石安全性和疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 635-639.
[15]	崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effectiveness of laparoscopic sleeve gastrectomy in treating obesity and the co-morbidities

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effectiveness of laparoscopic sleeve gastrectomy in treating obesity and the co-morbidities